B. Riley Securities Initiates MacroGenics With Buy Rating, $25 Price Target
MacroGenics (MGNX) has an average rating of buy and price targets ranging from $16 to $30, according to analysts polled by Capital IQ.
MT NewswiresApr 26 08:00 ET
We're Hopeful That MacroGenics (NASDAQ:MGNX) Will Use Its Cash Wisely
Yahoo FinanceApr 19 07:04 ET
Companies Like MacroGenics (NASDAQ:MGNX) Are In A Position To Invest In Growth
There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, MacroGenics (NASDAQ:MGNX) has seen its share price rise 157% over the last year, delighting ma
Simply Wall StApr 15 07:29 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Enlivex (ENLV), MacroGenics (MGNX) and Immuneering (IMRX)
TipRanksApr 12 06:30 ET
Express News | Macrogenics Shares Are Trading Higher After TD Cowen Upgraded the Stock From Hold to Buy
Moomoo 24/7Apr 9 08:28 ET
Macrogenics Raised to Buy From Hold by TD Cowen
Macrogenics Raised to Buy From Hold by TD Cowen
Dow JonesApr 9 06:47 ET
Express News | TD Cowen Upgrades Macrogenics to Buy
Moomoo 24/7Apr 9 06:37 ET
Macrogenics(MGNX.US) Officer Sells US$799.15K in Common Stock
$Macrogenics(MGNX.US)$ Officer Peters Jeffrey Stuart sold 51,395 shares of common stock on Apr 4, 2024 at an average price of $15.55 for a total value of $799.15K.Source: Announcement What is statemen
moomoo NewsApr 8 18:47 ET
Analysts Offer Insights on Healthcare Companies: Halozyme (HALO) and MacroGenics (MGNX)
TipRanksApr 8 04:00 ET
Look Out For These 6 Stocks As Analysts Predicts Major Gains, One Up To 82%
Investment analysts have revised their price targets upwards for six major stocks this week, with one company expected to see an 82% surge. The revised targets include four U.S.-listed companies, with
BenzingaApr 5 02:15 ET
Form 144 | Macrogenics(MGNX.US) Officer Proposes to Sell 798.79K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 4, $Macrogenics(MGNX.US)$ Officer Peters Jeffrey Stuart intends to sell 51,395 shares of its common stock on Apr 4, with a total market value of approximately $798.79K. P
moomoo NewsApr 4 17:02 ET
MacroGenics Analyst Impressed By Improved Safety Profile From Prostate Cancer Candidate
Wednesday, MacroGenics Inc (NASDAQ:MGNX) provided an update on the Phase 2 TAMARACK study of vobramitamab duocarmazine (vobra duo, previously known as MGC018) for metastatic castration-resistant prost
BenzingaApr 4 14:15 ET
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of STAAR Surgical Company (NASDAQ:STAA) rose sharply during Thursday's session after the company issued strong preliminary first-quarter net sales guidance. STAAR Surgical shares jumped 13.3%
BenzingaApr 4 13:21 ET
BRNS, UPC and KWE Among Mid-day Movers
Seeking AlphaApr 4 13:06 ET
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersCandel Therapeutics (NASDAQ:CADL) shares moved upwards by 64.3% to $2.76 during Thursday's regular session. The market value of their outstanding shares is at $80.9 million. TC BioPharm (Holdin
BenzingaApr 4 12:31 ET
MacroGenics Shares Surge Following Phase 2 Update on Prostate Cancer Drug
MacroGenics (MGNX) shares jumped 33% in recent trading Thursday, a day after the company said it will present updated clinical information in autumn on radiographic progression-free survival from the
MT NewswiresApr 4 11:33 ET
MacroGenics Up Nearly 32%, on Pace for Largest Percent Increase Since May 2020 -- Data Talk
MacroGenics, Inc. (MGNX) is currently at $18.00, up $4.34 or 31.71% --Would be highest close since March 7, 2024, when it closed at $20.51 --On pace for largest percent increase since May 6, 2020, w
Dow JonesApr 4 11:10 ET
Express News | JMP Securities Reiterates Market Outperform on Macrogenics
Moomoo 24/7Apr 4 08:56 ET
Sector Update: Health Care Stocks Lean Higher Pre-Bell Thursday
Health care stocks were leaning higher pre-bell Thursday, with the Health Care Select Sector SPDR Fund (XLV) unchanged and the iShares Biotechnology ETF (IBB) up 0.4%. MacroGenics (MGNX) said interim
MT NewswiresApr 4 08:55 ET
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Amid Renewed Rate Cut Hopes
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.4% and the actively traded Invesco QQQ Trust (QQQ) was 0.5% higher in Thursday's premarket activity amid renewed expectation
MT NewswiresApr 4 08:33 ET
No Data
No Data